Health Care: Drugs

Enzon Pharmaceuticals Inc. (ENZN: NASDAQ)

$0.8982 0.052 | 6.15%
04/15/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 0.85
52 Week High 4.02
52 Week Low 0.78
Avg. Daily Vol. (Mil) 0.57
Beta (3 year) 1.29
Share Related Items
Mkt Cap (Mil) 37.31
Shares Out (Mil) 44.09
Float (Mil) 24.90
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 1,014.00
Financial Strength
Quick Ratio 5.00
Current Ratio 5.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 2.40
Price/Sales 1.08
Price/Book 7.10
Price/Cash Flow 1.90
Per Share Data
Earnings 0.36
Sales 0.78
Book Value 0.12
Cash Flow 0.44
Business Summary
Enzon Pharmaceuticals, Inc. is engaged in the research and development of therapeutics for cancer patients primarily in the United States.
General Information
20 Kingsbridge Road
Piscataway, NJ 08854
www.enzon.com
Industry : Drugs
Sector: Health Care
Employees: 1
CEO:
Short Interest
Current Month (Mil) 1.37
Previous Month (Mil) 1.25
Short Interest Ratio (Days) 1.50
Management Effectiveness
Return on Equity 345.40
Return on Assets 254.90
Return on Investments 345.40
Profitability
Gross Margin n.a.
EBIT Margin 55.30
Profit Margin 52.60

Portfolios with ENZN

Latest ENZN Headlines from TheStreet

More Financial News for ENZN

Press Releases for ENZN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter